“Politics will lead you down many paths, but a conservative and a patriot will never be far from the Bow Group. Against the tide of globalism, liberalism, and Marxism the Bow Group stands resolute.

The Bow Group is where conservatism begins and ends in Britain, there is nowhere else like it.”

Ben Harris-Quinney, Bow Group Chairman

“It is my honour to accept the role of Senior Patron of the Bow Group, one of the very few conservative institutions that has been there throughout my life, and is ever renewing its commitment to conservatism…rather than demuring from it.”

Sir Roger Scruton, Bow Group Honorary Patron

“It’s so important to have a really strong intellectual base from which to develop policy, and the research material that began the Brexit movement and the Maastricht rebellion was a pamphlet published by the Bow Group. The Bow Group has always been at the heart of British and conservative patriotism.”

Sir Bill Cash MP, Bow Group Senior Patron

“All organisations that are not avowedly right-wing will eventually become left-wing.”

Dr John O’Sullivan, Bow Group Senior Patron

DONATE
Q

MAKE A DONATION

Donation amount
JOIN
SIGN UP
Q

Sign up to the Bow Group Mailing List

* indicates required



Conservative Revolution

Britain and the world’s oldest conservative think tank

Conservative Revolution

Britain and the world’s oldest conservative think tank

DONATE
JOIN
SIGN UP

Bow Group Open Letter to the Rt. Hon Matt Hancock MP, Secretary of State for Health and Social Care

Jul 30, 2018 | Archive, Policies

71-75 Shelton Street

Covent Garden

London

WC2H 9JQ

Rt. Hon Matthew Hancock MP

Secretary of State for Health and Social Care

Department of Health and Social Care

39 Victoria Street

London

SW1H 0EU


28th July 2018

Dear Secretary of State,


There have been numerous reports in the print and social media about the possibility of a shortage in time sensitive medicines such as insulin.


The USA and EU re leading suppliers but currently none is manufactured commercially within the UK. All medicines used by the NHS are licenced by the MHRA. All medicines approved by the European Medicines Agency are licenced in any case for use in the UK.


I have asked a leading United States supplier of insulin the following questions and I ask them also of you. It is important every effort is made to ensure supplies of essential medicine to and from the UK remain available during any transition arrangement with the EU or indeed without any deal.


1. If the MHRA allowed on a temporary basis unilateral licencing in the UK of Food & Drug Administration approved medicines and devices would there be any further hindrance to the UK importing insulin directly from the United States for the foreseeable future?


2.  If the USA and UK signed and ratified the pharmaceutical chapter (current draft) of TTIP, without a broader scope trade deal, would this provide a sustainable platform on which UK USA trade in pharmaceuticals could be carried out?


Accelerating a partial scope agreement with the United States on Pharmaceuticals and Medical Devices, given both have standalone chapters within the final draft of TTIP, would be an obvious route to ensuring supplies of essential healthcare products.


While the process of making such arrangements falls outside the remit of the DoH, the outcome of such an agreement would be felt by it.


3. Has the DoH previously mooted any such partial scope agreement with any major trading area given the importance of essential medicines to the healthcare of the nation?  


Best wishes


Mr. Jonathan Stanley MBChB MRCS(Eng) PGHEM

 

Health Research Fellow, Bow Group

Contact us 

The Bow Group

71-75 Shelton Street Covent Garden London  WC2H 9JQ

Tel: 07875 570 898 

Email: office@bowgroup.org

Copyright © The Bow Group MMXX | All Rights Reserved | Privacy Policy